Đang chuẩn bị liên kết để tải về tài liệu:
Secondary pulmonary alveolar proteinosis complicating myelodysplastic syndrome results in worsening of prognosis: A retrospective cohort study in Japan

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ

Secondary pulmonary alveolar proteinosis (sPAP) is a very rare lung disorder comprising approximately 10% of cases of acquired PAP. Hematological disorders are the most common underlying conditions of sPAP, of which 74% of cases demonstrate myelodysplastic syndrome (MDS). However, the impact of sPAP on the prognosis of underlying MDS remains unknown. |

TÀI LIỆU LIÊN QUAN

Secondary pulmonary alveolar proteinosis complicating myelodysplastic syndrome results in worsening of prognosis: A retrospective cohort study in Japan

Secondary pulmonary alveolar proteinosis: A single-center retrospective study (a case series and literature review)

Effectiveness of the Assessment of Burden of Chronic Obstructive Pulmonary Disease (ABC) tool: Study protocol of a cluster randomised trial in primary and secondary care

Serum uric acid is associated with disease severity and may predict clinical outcome in patients of pulmonary arterial hypertension secondary to connective tissue disease in Chinese: A single-center retrospective study

Diffuse persistent pulmonary interstitial emphysema secondary to mechanical ventilation in bronchiolitis

Atrial septostomy and disease targeting therapy in pulmonary hypertension secondary to neurofibromatosis

Secondary left heart failure occurred during VA-ECMO assistance for severe residual pulmonary hypertension after pulmonary endarterectomy: A case report

Decline in air pollution and change in prevalence in respiratory symptoms and chronic obstructive pulmonary disease in elderly women

Comparison of clinical features and prognosis in patients with cryptogenic and secondary organizing pneumonia

Use of sildenafil in an infant with persistent pulmonary hypertension secondary to lung and renal hypoplasia – a case report